Anthony Pick is an Endocrinology/Metabolic physician affiliated with Northwestern University. OpenAlex indexes 14 publications with 663 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
111 S Pfingsten Rd Ste 300
Deerfield, IL 600154981
Telephone
847-597-1980Provider last certified this registry record 19 Dec 2025.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year202538 payments$34,810openpaymentsdata.cms.gov ↗
- Lilly USA, LLCProgram year202541 payments$21,857openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year202536 payments$20,135openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
65.4%GLP-1 receptor agonist25.2%Ozempic42%Mounjaro30%Trulicity17%Rybelsus9%Victoza 3-Pak1%Part D<11 patientsInsulin Analog18%Tresiba Flextouch U-10018%Lantus Solostar14%Humalog Kwikpen U-10014%Novolog Flexpen9%Fiasp Flextouch8%Basaglar Kwikpen U-1007%Humalog6%Tresiba Flextouch U-2006%Novolog5%Toujeo Solostar5%Toujeo Max Solostar3%Xultophy 100-3.62%Fiasp2%Insulin Lispro Kwikpen U-1002%Part D<11 patients+ 11 more classes in this area
Cardiovascular
17.9%Statin9.1%Atorvastatin Calcium44%Rosuvastatin Calcium40%Pravastatin Sodium9%Simvastatin9%Part D<11 patientsCholesterol absorption inhibitor4.8%Ezetimibe100%Part D≥71 patients+ 7 more classes in this area
Hormonal (systemic)
12.8%l-Thyroxine10.7%Levothyroxine Sodium60%Synthroid28%Levoxyl6%Unithroid4%Tirosint3%Part D<11 patientsl-Triiodothyronine1.1%Liothyronine Sodium100%Part D≥14 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- NURSE PRACTITIONER-LED, TEAM-BASED CARDIOVASCULAR-KIDNEY-METABOLIC CLINIC IMPROVES OUTCOMES: INITIAL EXPERIENCE IN AN AMBULATORY PRACTICE
Journal of the American College of Cardiology
2025 - Continuous Glucose Monitoring in a Patient With Insulin-Treated Type 2 Diabetes
Clinical Diabetes
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University
Philip Greenland, MD
Northwestern University
Peter Kahrilas, MD
Northwestern University
Philip Gorelick, MD
Northwestern University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”